SFWC
SEEL

Strategic Family Wealth Counselors’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Strategic Family Wealth Counselors’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-234
Closed -$17.7K – 127
2024
Q1 		$17.7K Hold
234
– – 0.01% 117
2023
Q4 		$41.7K Buy
234
+195
+500% +$96K 0.02% 116
2023
Q3 		$27.7K Hold
39
– – 0.01% 109
2023
Q2 		$179K Buy
39
+10
+34% +$34.7K 0.08% 106
2023
Q1 		$77.4K Buy
29
+2
+7% +$5.86K 0.04% 105
2022
Q4 		$69.3K Buy
+27
New +$94.2K 0.03% 104

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $9.37B AUM 23.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $282M AUM 32.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Strategic Family Wealth Counselors's SEEL Position: Q2 2024 in Review

Strategic Family Wealth Counselors sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q2 2024, closing a stake of 234 shares — an estimated $17.7K sold.

Strategic Family Wealth Counselors first reported a position in SEEL in Q4 2022 and held it in 6 quarters. The position peaked at $179K in Q2 2023. 18 funds tracked by Wall St. Rank hold SEEL as of Q2 2024.

  • Strategic Family Wealth Counselors reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Strategic Family Wealth Counselors sold 234 Seelos Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $17.7K.
  • Strategic Family Wealth Counselors first reported a position in Seelos Therapeutics, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Strategic Family Wealth Counselors's Seelos Therapeutics, Inc. Common Stock position peaked at $179K in Q2 2023.
  • 18 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Strategic Family Wealth Counselors's 13F filing for Q2 2024, filed 14 Aug 2024.